Determinants of multidrug-resistant tuberculosis in South Africa: Results from a national survey

South African Medical Journal

Volumn 97, Issue 11 III, 2007, Pages 1120-1128

  Weyer, Karin ^a   Brand, J ^a   Lancaster, J ^a   Levin, J ^a   Van der Walt, M ^a  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIDRUG RESISTANCE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; RETREATMENT; SEX RATIO; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; COINFECTION; DATA COLLECTION; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 37349072092     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Global Tuberculosis Control. Surveillance, Planning, Financing. WHO/HTM/TB/2007.376, WHO Report 2007. World Health Organization, Geneva, Switzerland, 2007.
2. Weyer K, Fourie PB, Nardell EA. A Noxious Synergy: Tuberculosis and HIV in South Africa. In: The Gobal Impact of Drug-Resistant Tuberculosis. Harvard Medical School and Open Society Institute, Boston, USA, 1999.
3. The South African Tuberculosis Control Programme. Practical Guidelines 1996, first revision 2000. Department of Health - Directorate of Tuberculosis Control, Pretoria, South Africa, 2000.
4. Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. Morb Mortal Wkly Rep 2006; 55(11): 301-305.
5. Weyer K, Kleeberg HH. Primary and acquired drug resistance in adult black patients with tuberculosis in South Africa: results of a continuous national drug resistance surveillance programme involvement. Tuberc Lung Dis 1992; 73: 106-112.
6. Weyer K, Groenewald P, Zwarenstein M, Lombard CJ. Tuberculosis drug resistance in the Western Cape. S Afr Med J 1995; 85(6): 499-504.
7. Weyer K, Lancaster J, Balt E, Dürrheim D. Tuberculosis drug resistance in Mpumalanga province, South Africa. Int J Tuberc Lung Dis 1998; 2(11) Suppl 2, S569-PD (Abstract).
8. The Management of Multidrug-Resistant Tuberculosis in South Africa. 2nd ed. Department of Health: Directorate Tuberculosis Control, Pretoria, South Africa, 1999.
9. Guidelines for Surveillance of Drug Resistance in Tuberculosis. World Health Organization, Geneva, Switzerland, 2002.
10. Bennett S, Woods AJ, Liyanage WM, Smith DL. A simplified general method for cluster sample surveys of health in developing countries. World Health Quarterly 1991; 44: 98-106.
11. Laboratory Services in Tuberculosis Control. Part II: Microscopy. WHO/ TB/98.258. World Health Organization, Geneva, Switzerland, 2002.
12. Laboratory Services in Tuberculosis Control. Part III: Culture. WHO/ TB/98.258. World Health Organization, Geneva, Switzerland, 2002.
13. Rao JNK, Scott AJ. The analysis of categorical data from complex sample surveys: chisquared tests for goodness of fit and independence in two-way tables. J Am Statistics Ass 1981; 76: 221-230.
14. Rao JNK, Scott AJ. On chi-squared tests for multiway contingency tables with cell proportions estimated from survey data. Annals of Statistics 1984; 12: 46-60.
15. Skinner CJ. Domain means, regression and multivariate analysis. In: Skinner CJ, Holt D, Smith TFM, eds. Analysis of Complex Surveys. Chichester, England: Wiley, 1989.
16. Tuberculosis Case Finding and Treatment Outcome Reports. Department of Health: Directorate Tuberculosis Control, Pretoria, South Africa, 2004.
17. Report: 2002 National HIV Sero-prevalence Survey of Women Attending Public Antenalal Clinics in South Africa. Department of Health: Directorate Health Systems and Epidemiology, Pretoria, South Africa, 2003.
18. Anti-Tuberculosis Drug Resistance in the World. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. WHO/TB/ 97.229. World Health Organization, Geneva, Switzerland, 1997.
19. Anti-Tuberculosis Drug Resistance in the World. Report No. 2: Prevalence and Trends. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. WHO/CDS/TB/2000.278. World Health Organization, Geneva, Switzerland, 2000.
20. Anti-Tuberculosis Drug Resistance in the World. Report No. 3: Prevalence and Trends. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. WHO/CDS/TB/2000.278. World Health Organization, Geneva, Switzerland, 2005.
21. Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2002; 185: 1197-1202.
22. Zignol M, Hosseini MS, Wright A, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006; 194: 479-485.
23. Sacks LV, Pendle S, Orlovic D, Blumberg L. A comparison of outbreak- and non-outbreak-related multidrug resistant tuberculosis among human immunodeficiency virus-infected patients in a South African hospital. Clin Infect Dis 1999; 29(1): 96-101.
24. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1554-1556.